Eric Tetzlaff, PA-C
National Commission on Certification of Physician Assistants;
Pennsylvania State Board of Medicine
I chose to work at Fox Chase Cancer so that I could continue my career in oncology at an academic cancer center dedicated to providing quality care.
After graduating from the Duke University's Physician Assistant program in 2004, I began my career in oncology as a physician assistant at the M.D. Anderson Cancer Center in Texas.
At M.D. Anderson, I worked in the department of gastrointestinal medical oncology for four years specializing in the treatment of gastroesophageal and hepatobiliary cancers. I had the opportunity to publish several manuscripts in peer reviewed journals and present original research at national oncology conferences.
At Fox Chase, I am focusing on the clinical care of patients with sarcomas and gastrointestinal cancers.
Duke University, Durham, N.C., Master of Health Sciences, Physician Assistant Program, 2004
Gastrointestinal Cancers Gastrointestinal Survivorship Care; Thromboembolism and Cancer
Research & Publications:
1. Tetzlaff ED, Davey M. Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumors. Journal of Advanced Practitioner in Oncology 2012; Submitted
2. Tetzlaff ED, Cen, P, Ajani JA. Emerging drugs in the treatment of advanced gastric cancer. Expert Opinion on Emerging Drugs 2008; 13:135-144.
3. Tetzlaff ED, Correa AM, Komaki R, Swisher SG, Ross W, Ajani JA. The significance of thromboembolic phenomena occurring before and during chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Diseases of the Esophagus 2008; 21:575-581.
4. Tetzlaff ED, Correa AM, Baker J, Ensor J, Ajani JA. Impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma. Cancer 2007; 109:1989-1995.